Recent Updates
Recently added Catalysts
ABT Positive Sentiment Score: 85/100

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 Abbott (NYSE: ABT) will present 11 abstracts featuring new evidence across the cancer care continuum at the American Society of Clinical Oncology...

Tuesday, May 26, 2026 1 min read
Key Takeaway: Abbott (NYSE: ABT) is set to present 11 abstracts at the American Society of Clinical Oncology (ASCO) 2026, showcasing new evidence across cancer diagnostics. This includes advancements in tests such as the Cancerguard® Multi-Cancer Early Detection Test and the Oncodetect® Molecular Residual Disease Test. The presentations reflect Abbott's continuous efforts and innovations in the cancer care continuum, signifying their commitment to improving patient outcomes through advanced diagnostics.

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation of 11 abstracts signifies strong ongoing research.
  • Showcases advances in multiple cancer diagnostics technologies.
  • Highlights Abbott's leadership in cancer care innovations.
  • Focus on multi-cancer early detection demonstrates commitment to improving outcomes.

Full Press Release Details

Abstract Presentations at ASCO 2026
The Cancerguard ® Multi-Cancer Early Detection (MCED) Test
Session times: Monday, June 1, 2026, from 1:30 p.m. to 4:30 p.m. CT
The Oncodetect ® Molecular Residual Disease (MRD) Test
Session times: Monday, June 1, 2026, from 1:30 p.m. to 4:30 p.m. CT
The Oncotype DX Breast Recurrence Score ® Test
Session times: Monday, June 1, 2026, from 1:30 p.m. to 4:30 p.m. CT
Session time: Monday, June 1, 2026, at 10:51 a.m.
Pipeline Innovation
Session time: Monday, June 1, 2026, from 9:00 a.m. to 12:00 p.m. CT
The Cologuard ® Test
Session time: Online Only
About Abbott Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at abbott.com and on LinkedIn , Facebook , Instagram , X and YouTube .

21 %

Frequently Asked Questions

When are the presentations for the MCED Test at ASCO 2026?

The MCED Test presentations are on June 1, 2026, from 1:30 p.m. to 4:30 p.m. CT.

What time is the Pipeline Innovation session at ASCO 2026?

The Pipeline Innovation session is on June 1, 2026, from 9:00 a.m. to 12:00 p.m. CT.

Is the Cologuard Test session online only?

Yes, the Cologuard Test session is available online only.

When does the Oncotype DX session take place?

The Oncotype DX session occurs on June 1, 2026, at 10:51 a.m. CT.

What date is the ASCO 2026 conference?

The ASCO 2026 conference is on June 1, 2026.

Tags: ABT Viatris Investor Conferences Healthcare Abbott ASCO cancer care Oncodetect Cancerguard
Last updated: May 26, 2026